A. Yes. Dr. Gunn has published numerous research papers in the peer-reviewed medical literature. His clinical model is a more comprehensive elaboration of widely accepted approaches to the treatment of myofascial pain syndromes. It is properly defined as a type of trigger point therapy, although in contrast to trigger point injections, it provides a more systematic and thorough neuro-musculo-skeletal model and physical examination within which the needle therapy is but the final point (pun intended!).

Indeed, numerous research studies on trigger point injections have shown not only their effectiveness, but significantly, that there was absolutely no additional lasting benefit (and potential harm) from actually injecting something (saline, local anesthetic, steroid) into the muscle compared with a 'dry' injection. It has been well documented that it is what is referred to as 'the needle effect' that produces the healing response. Dry injection is also referred to as 'dry needling'. IMS, Intramuscular Stimulation is yet a more advanced type of dry needling.

Return for a moment to Dr. Gunn's published research, as mentioned above. Not only did the results show significantly decreased pain and disability in those who received IMS, but the patients came from a pool of injured workers, who typically represent the most challenging patients to treat and return to work.

DR. GUNN'S PUBLISHED RESEARCH ON IMS FOR CHRONIC LOW BACK PAIN
SPINE JOURNAL 1980

CLICK HERE TO VIEW ADDITIONAL INDEPENDENTLY PUBLISHED RESEARCH THAT PROVES IMS EFFECTIVENESS

           TRIGGER POINT THERAPY FOR  MYOFASCIAL PAIN SYNDROMES HAS BEEN VALIDATED BY NUMEROUS STUDIES.

           IMS IS YET A MORE COMPREHENSIVE FORM OF TRIGGER POINT TREATMENT .